Vasculopathy in two cases of NF1-related congenital pseudarthrosis

Pathology Research and Practice

Volumn 202, Issue 9, 2006, Pages 687-690

  Kuorilehto, Tommi ^a,b,c   Kinnunen, Pentti ^c   Nissinen, Marja ^a   Alanne, Maria ^b   Leskelä, Hannu Ville ^b   Lehenkari, Petri ^b   Peltonen, Juha ^a,c  

^a UNIVERSITY OF TURKU   (Finland)

^b UNIVERSITY OF OULU   (Finland)

^c OULU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Neurofibromatosis type 1; Pediatric orthopedics; Pseudarthrosis; Vasculopathy

Indexed keywords

GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NEUROFIBROMIN; PROTEIN S 100;

ARTERY WALL; ARTICLE; CASE REPORT; CELL LABELING; CELL SUBPOPULATION; CLINICAL FEATURE; CONGENITAL PSEUDARTHROSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOTHELIUM CELL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; JOINT SURGERY; MALE; NEUROFIBROMATOSIS; PRESCHOOL CHILD; PROTEIN DETERMINATION; PROTEIN EXPRESSION; VASCULAR DISEASE; VASCULAR ENDOTHELIUM; VEIN WALL;

EID: 33747351787     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2006.03.006     Document Type: Article

References (12)

1. Friedman J.M. Neurofibromatosis 1: Clinical manifestations and diagnostic criteria. J. Child Neurol. 17 (2002) 548-554
2. Friedman J.M., Arbiser J., Epstein J.A., Gutmann D.H., Huot S.J., Lin A.E., McManus B., and Korf B.R. Cardiovascular disease in neurofibromatosis 1: Report of the nf1 cardiovascular task force. Genet. Med. 4 (2002) 105-111
3. Friedman J.M., and Birch P.H. Type 1 neurofibromatosis: A descriptive analysis of the disorder in patients 1728. Am. J. Med. Genet. 70 (1997) 138-143
4. Gitler A.D., Zhu Y., Ismat F.A., Lu M.M., Yamauchi Y., Parada L.F., and Epstein J.A. Nf1 has an essential role in endothelial cells. Nat. Genet. 33 (2003) 75-79
5. Hermanns-Sachweh B., Senderek J., Alfer J., Klosterhalfen B., Buttner R., Fuzesi L., and Weber M. Vascular changes in the periosteum of congenital pseudarthrosis of the tibia. Pathol. Res. Pract. 201 (2005) 305-312
6. Ippolito E., Corsi A., Grill F., Wientroub S., and Bianco P. Pathology of bone lesions associated with congenital pseudarthrosis of the leg. J. Pediatr. Orthop. B 9 (2000) 3-10
7. J. Koivunen, S.L. Karvonen, H. Yla-Outinen, V. Aaltonen, A. Oikarinen, J. Peltonen, Nf1 tumor suppressor in epidermal wound healing with special focus on wound healing in patients with type 1 neurofibromatosis. Arch. Dermatol. Res. (2005).
8. Kuorilehto T., Ekholm E., Nissinen M., Hietaniemi K., Hiltunen A., Paavolainen P., Penttinen R., and Peltonen J. Nf1 gene expression in mouse fracture healing and in experimental rat pseudarthrosis. J. Histochem. Cytochem. 54 (2006) 363-370
9. Kuorilehto T., Nissinen M., Koivunen J., Benson M.D., and Peltonen J. Nf1 tumor suppressor protein and mRNA in skeletal tissues of developing and adult normal mouse and nf1-deficient embryos. J. Bone Miner. Res. 19 (2004) 983-989
10. Lammert M., Friedman J.M., Kluwe L., and Mautner V.F. Prevalence of neurofibromatosis 1 in German children at elementary school enrollment. Arch. Dermatol. 141 (2005) 71-74
11. Vasioukhin V., Bauer C., Degenstein L., Wise B., and Fuchs E. Hyperproliferation and defects in epithelial polarity upon conditional ablation of alpha-catenin in skin. Cell 104 (2001) 605-617
12. Zachos M., Parkin P.C., Babyn P.S., and Chait P. Neurofibromatosis type 1 vasculopathy associated with lower limb hypoplasia. Pediatrics 100 (1997) 395-398